Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30(16):R921–R925

Article  PubMed  PubMed Central  Google Scholar 

Bai X, Guo YR, Zhao ZM, Li XY, Dai DQ et al (2025) Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies. Cancer Lett 625:217772

Article  PubMed  Google Scholar 

Bates M, Mohamed BM, Lewis F, O’Toole S, O’Leary JJ (2024) Biomarkers in high grade serous ovarian cancer. Biochim Biophys Acta Rev Cancer 1879(6):189224

Article  PubMed  Google Scholar 

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17(1):218

Article  PubMed  PubMed Central  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL et al (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263

Google Scholar 

Cao K, Zhang G, Yang M, Wang Y, He M et al (2023) Attenuation of sialylation augments antitumor immunity and improves response to immunotherapy in ovarian cancer. Cancer Res 83(13):2171–2186

Article  PubMed  Google Scholar 

Caruso G, Weroha SJ, Cliby W (2025) Ovarian cancer: a review. JAMA 334(14):1278–1291

Article  PubMed  Google Scholar 

Chang H, Dong T, Ma X, Zhang T, Chen Z et al (2015) Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma. Biochem Biophys Res Commun 464(1):45–50

Article  PubMed  Google Scholar 

Dai W, Huang HL, Hu M, Wang SJ, He HJ et al (2015) microRNA-506 regulates proliferation, migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1). Am J Cancer Res 5(9):2697–2707

PubMed  PubMed Central  Google Scholar 

de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374–403

Article  PubMed  Google Scholar 

Drew Y, Kim JW, Penson RT, O’Malley DM, Parkinson C et al (2024) Olaparib plus Durvalumab, with or without Bevacizumab, as treatment in PARP Inhibitor-naïve platinum-sensitive relapsed ovarian cancer: a phase II multi-cohort study. Clin Cancer Res 30(1):50–62

Article  PubMed  PubMed Central  Google Scholar 

Ghisoni E, Morotti M, Sarivalasis A, Grimm AJ, Kandalaft L et al (2024) Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach. Nat Rev Clin Oncol 21(11):801–817

Article  PubMed  Google Scholar 

Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W et al (2017) Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer. JAMA Oncol 3(12):e173290

Article  PubMed  PubMed Central  Google Scholar 

Harada K, Sakamoto N, Kitaoka T, Nakamura Y, Kondo R et al (2025) PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer. J Pathol 265(4):472–485

Article  PubMed  PubMed Central  Google Scholar 

Huang Y, Xiong C, Wang C, Deng J, Zuo Z et al (2023) p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. Cell Rep 42(11):113426

Article  PubMed  Google Scholar 

Huang X, Li X, Shan W, Dou Y, Yu Q et al (2025) Integrating single-cell and bulk RNA sequencing data to explore sphingolipid metabolism molecular signatures in ovarian cancer prognosis: an original study. Int J Med Sci 22(8):1958–1977

Article  PubMed  PubMed Central  Google Scholar 

Huo Y, Yang J, Zheng J, Xu D, Yang M et al (2022) Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling. Cell Prolif 55(5):e13237

Article  PubMed  PubMed Central  Google Scholar 

Jiang P, Gu S, Pan D, Fu J, Sahu A et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550–1558

Article  PubMed  PubMed Central  Google Scholar 

Johnson DE, O’Keefe RA, Grandis JR (2018) Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15(4):234–248

Article  PubMed  PubMed Central  Google Scholar 

Klar A, Baldassare M, Jessell TM (1992) F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cell 69(1):95–110

Article  PubMed  Google Scholar 

Landen CN, Buckanovich RJ, Sill MW, Mannel RS, Walker JL et al (2024) Phase I and randomized phase II study of ruxolitinib with frontline neoadjuvant therapy in advanced ovarian cancer: an NRG oncology group study. J Clin Oncol 42(21):2537–2545

Article  PubMed  PubMed Central  Google Scholar 

Li T, Fan J, Wang B, Traugh N, Chen Q et al (2017) TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77(21):e108–e110

Article  PubMed  PubMed Central  Google Scholar 

Lin YB, Xu BH (2023) N6-methyladenosine methyltransferase METTL3 Enhances PTGER2 expression to increase ovarian cancer stemness and chemoresistance. Front Biosci (Landmark Ed) 28(9):199

Article  PubMed  Google Scholar 

Miyakawa R, Kobayashi M, Sugimoto K, Endo Y, Kojima M et al (2023) SPON1 is an independent prognostic biomarker for ovarian cancer. J Ovarian Res 16(1):95

Article  PubMed  PubMed Central  Google Scholar 

Mollaoglu G, Tepper A, Falcomatà C, Potak HT, Pia L et al (2024) Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell 187(26):7492-7510.e7422

Article  PubMed  PubMed Central  Google Scholar 

Nagasawa S, Ikeda K, Shintani D, Yang C, Takeda S et al (2022) Identification of a novel oncogenic fusion gene SPON1-TRIM29 in clinical ovarian cancer that promotes cell and tumor growth and enhances chemoresistance in A2780 cells. Int J Mol Sci 23(2):689

Article  PubMed  PubMed Central  Google Scholar 

Odunsi K, Qian F, Lugade AA, Yu H, Geller MA et al (2022) Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses. Sci Transl Med 14(636):eabg8402

Article  PubMed  PubMed Central  Google Scholar 

Ou SI, Xiu J, Nagasaka M, Xia B, Zhang SS et al (2021) Identification of novel CDH1-NRG2α and F11R-NRG2α fusions in NSCLC plus additional novel NRG2α fusions in other solid tumors by whole transcriptome sequencing. JTO Clin Res Rep 2(2):100132

PubMed  Google Scholar 

Park S, Yoon B, Kim S, Kim S (2019) GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genomics 12(Suppl 5):101

Article  PubMed  PubMed Central  Google Scholar 

Park SY, Kang JY, Lee T, Nam D, Jeon CJ et al (2020) SPON1 can reduce amyloid beta and reverse cognitive impairment and memory dysfunction in Alzheimer’s disease mouse model. Cells 9(5):1275

Article  PubMed  PubMed Central  Google Scholar 

Qi Y, Zhang W, Li X, Shi Y, Qu P (2026) A systematic CRISPR screen reveals an NBL1-mediated Jak/Stat3 crosstalk to promote ovarian cancer metastasis. Genes Dis 13(1):101740

Article  PubMed  Google Scholar 

Reina-Campos M, Scharping NE, Goldrath AW (2021) CD8(+) T cell metabolism in infection and cancer. Nat Rev Immunol 21(11):718–738

Article  PubMed  PubMed Central  Google Scholar 

Rincón-Rodriguez R, Mena D, Mena J, Díaz-Saldivar P, Guajardo-Correa E et al (2019) F-spondin is the signal by which 2-methoxyestradiol induces apoptosis in the endometrial cancer cell line Ishikawa. Int J Mol Sci 20(16):3850

Article  PubMed  PubMed Central  Google Scholar 

Rodman EPB, Emch MJ, Hou X, Bajaj A